Concepedia

Shu-Qun Li

SL

Statistics

Publications

8

Citations

171

H-Index

8

Active since

2014

Affiliations

Guilin Medical University(Current)

Fujian Medical University

Fujian Provincial Hospital

Zhongshan Hospital of Xiamen University

Zhangzhou Municipal Hospital of Fujian Province

Shu-Qun Li is an author at Guilin Medical University specializing in hepatology, medicine, and hepatocellular carcinoma.

Top concepts

Publications per year

2014–2024

8

Publications

8

Aflatoxin B1 Promotes Cell Growth and Invasion in Hepatocellular Carcinoma HepG2 Cells through H19 and E2F1

Jun Lv, Yaqun Yu, Shu-Qun Li et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 63 citations · Full text

Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

Shu-Qun Li, Jiayi Wu, Huang Xie et al. · Journal of Hepatocellular Carcinoma · 2023 · 23 citations · Full text

Long Intergenic Nonprotein Coding RNA 0152 Promotes Hepatocellular Carcinoma Progression by Regulating Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway through miR-139/PIK3CA

Shu-Qun Li, Qian Chen, Huixia Qin et al. · American Journal Of Pathology · 2020 · 22 citations · Full text

Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study

Jiayi Wu, Yang-Kai Fu, Xiang-Ye Ou et al. · Annals of Surgical Oncology · 2024 · 15 citations

, , +10

Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery

Zhen-Xin Zeng, Jiayi Wu, Junyi Wu et al. · Liver Cancer · 2024 · 14 citations · Full text

1–5 of 8